Research Made in Germany Europe’s Largest Pharma Market is Regaining a Leading Position in R&D Von Dr. Thilo Kaltenbach und Sebastian Herzig Erschienen in: Regions & Locations Guide 01/2008
In its role as the world’s third largest market for medical drugs, Germany is a natural focus of international pharmaceutical corporations. Despite the €33 billion market size, as a R&D location Germany maintains a mixed reputation. Although research in Germany recognized as contributing high-end intellectual property to the international innovation chain, the pharmaceutical research landscape probably is too fragmented, processes too slow and market orientation of institutional research appears to be too limited, in order to quickly bring commercially successful products to the market.
